| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 06/02/2009 | CA2503900C Purine compounds and use thereof as cannabinoid receptor ligands |
| 05/28/2009 | WO2009067621A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | WO2009067600A2 Biaryl pde4 inhibitors for treating inflammation |
| 05/28/2009 | WO2009043320A3 Substituted 6-(alkylbenzylamino)purine derivatives for use as cytokinin receptor antagonists and preparations containing these derivatives |
| 05/28/2009 | US20090137802 A2b adenosine receptor antagonists |
| 05/28/2009 | US20090137801 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| 05/28/2009 | US20090137624 anticancer agents; tyrosine kinase inhibitors based on pyrazole-3-amine linked through amine to fused heterocyclic ring such as benzimidazole, or imidazo[4,5-b]pyridine; e.g. N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-(1-(4-fluorophenyl)ethyl)-3H-imidazo[4,5-b]pyridin-5-amine |
| 05/28/2009 | US20090137581 Heterocyclic compounds and their uses |
| 05/28/2009 | CA2722611A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | CA2722582A1 Biaryl pde4 inhibitors for treating inflammation |
| 05/27/2009 | EP2061794A2 2-phenoxy pyrimidinone analogues |
| 05/27/2009 | EP2061793A2 Kw-3902 conjugates that do not cross the blood-brain barrier |
| 05/27/2009 | EP2061470A2 Haloalkyl-substituted pyrimidinone derivatives |
| 05/27/2009 | CN101443021A Prevention and treatment of cancer and other diseases |
| 05/27/2009 | CN100491377C Guanine one-pot synthesis method |
| 05/22/2009 | WO2009064471A1 Method of synthesis of morpholino oligomers |
| 05/22/2009 | WO2009063235A1 Derivatives of 1,9-dihydro-6h-purin-6-one and uses thereof-018 |
| 05/22/2009 | WO2008077557A8 8-ethinylxanthine derivatives as selective a2a receptor antagonists |
| 05/22/2009 | CA2704261A1 Method of synthesis of morpholino oligomers |
| 05/21/2009 | US20090131459 2-Thioxanthine Derivatives Acting as MPO-Inhibitors |
| 05/21/2009 | US20090131458 Compounds |
| 05/21/2009 | US20090131432 type II diabetes mellitus and obesity; dipeptidylpeptidase-IV (DPP-IV) inhibitor; 1-[2-(2-formylaminophenyl)-2-oxoethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-(3-aminopiperidin-1-yl)xanthine (xanthine=3,7-dihydro-purine-2,6-dione) |
| 05/21/2009 | US20090131370 Novel Nucleoside Derivatives |
| 05/20/2009 | EP2060573A2 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine |
| 05/20/2009 | CN101438288A Regulation of phosphoryl transferase activity of glutamine synthetase |
| 05/20/2009 | CN101437823A Polymorphs |
| 05/20/2009 | CN101437778A Reaction reagent for trifluoromethylation |
| 05/20/2009 | CN100488952C 5-phenyl pyridine, its preparation method and intermediate product and uses in controlling harmful fungus |
| 05/19/2009 | CA2336634C Antiviral macrocyclic compounds |
| 05/14/2009 | WO2009062059A2 Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors |
| 05/14/2009 | WO2009037357A4 Benzimidazole nf- kappab inhibitors |
| 05/14/2009 | US20090124796 Nucleobase Having Perfluoroalkyl Group and Process for Producing the Same |
| 05/13/2009 | EP2058311A2 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine |
| 05/13/2009 | EP2057159A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 05/13/2009 | EP1751158A4 Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation |
| 05/13/2009 | EP1515972B1 Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 05/13/2009 | EP1305026B1 Barbituric acid analogs as therapeutic agents |
| 05/13/2009 | CN101432261A N-benzoyl-and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 05/12/2009 | US7531544 Xanthine phosphodiesterase V inhibitors |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/07/2009 | WO2009006389A3 Pyrimidine derivatives useful as raf kinase inhibitors |
| 05/07/2009 | WO2007075572A3 Orally active purine-based inhibitors of heat shock protein 90 |
| 05/07/2009 | US20090118502 organic or inorganic salt of N-{3-[4'-(4-Aminomethyl-[1,2,3]triazol-1-ylmethyl)-2-fluoro-biphenyl- 4-yl]-2-oxo-oxazolidin-5-(S)-ylmethyl}-acetamide; anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents |
| 05/07/2009 | US20090118309 Selective antagonists of A2A adenosine receptors |
| 05/07/2009 | US20090118308 2,2-Bis-(hydroxymethyl)cyclopropylidenemethyl-Purines and -Pyrimidines As Antiviral Agents |
| 05/07/2009 | US20090118263 Novel Adenine Compound |
| 05/06/2009 | EP2054415A1 Adenosine receptor antagonists |
| 05/06/2009 | CN101426791A Purine derivatives with activity to the adenosine A2A receptor |
| 05/06/2009 | CN101426785A Adenosine A3 receptor agonists |
| 05/06/2009 | CN100484935C Benzimidazole-derivatives as factor Xa inhibitors |
| 05/05/2009 | US7528252 Derivatives of triazoly-imidazopyridine useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 04/30/2009 | WO2009053716A1 Purine derivatives useful as pi3 kinase inhibitors |
| 04/30/2009 | US20090111805 Bicyclic heteroaromatic derivatives useful as anticancer agents |
| 04/30/2009 | CA2703138A1 Purine derivatives useful as pi3 kinase inhibitors |
| 04/29/2009 | EP1758905B1 8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use in the form of a ddp-iv inhibitor |
| 04/29/2009 | CN101421271A Purine derivatives as adenosine receptor activator |
| 04/29/2009 | CN101421270A Narcotine purification process |
| 04/29/2009 | CN101420959A Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine A2A receptor agonists |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524847 Inhibit Dipeptidyl peptidase-IV; 7-(2-Butynyl)-3-methyl-3,7-dihydropurine-2,6-dione; suppress degradation of Glucagon-Like Peptide-1; enhance action of incretin; facilitate insulin secretion from pancreatic beta -cells due to glucose stimulus; postchallenge hyperglycemia, improved oral glucose tolerance |
| 04/23/2009 | WO2009050199A1 Purine derivatives as adenosine al receptor ligands |
| 04/23/2009 | WO2008131501A3 New anti-viral nucleoside analogs |
| 04/23/2009 | US20090105476 Organic Compounds |
| 04/23/2009 | US20090105212 Immunomoderators; antiallergens; viricides; bactericides; anticancer agents; rhinitis; hepatitis; skin disorders |
| 04/23/2009 | CA2703039A1 Purine derivatives as adenosine a1 receptor ligands |
| 04/22/2009 | EP2049491A1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| 04/21/2009 | US7521554 A2B adenosine receptor antagonists |
| 04/21/2009 | US7521454 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis |
| 04/21/2009 | US7521446 4-({8-[(2,6-Difluorophenyl)amino]-9-cyclopentylpurin-2-yl}amino) trans-cyclohexan-1-ol; mitogen-activated protein (tyrosine) kinase inhibitor; anticarcinogenic, antiinflammatory, analgesic agent, cardiovascular disease, renal disease, autoimmune condition, macular degeneration, pulmonary hypertension |
| 04/16/2009 | WO2009048474A1 2,7,9-substituted purinone derivatives for immunosuppression |
| 04/16/2009 | WO2008153947A3 Heterocyclic compounds as raf kinase modulators |
| 04/16/2009 | US20090099216 Novel adenine compound |
| 04/16/2009 | US20090099214 Organic Compounds |
| 04/16/2009 | US20090099213 Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors |
| 04/16/2009 | US20090099177 Pyridyl compounds |
| 04/15/2009 | EP2046792A2 Process for the preparation of tenofovir |
| 04/15/2009 | CN101410388A Compounds for the treatment of inflammatory disorders |
| 04/15/2009 | CN101407517A Preparation of ambroxol theophylline-7-acetate |
| 04/15/2009 | CN100478343C Purine compound and use as cannabinoid receptor ligands |
| 04/14/2009 | US7517990 Method for deuteration of a heterocyclic ring |
| 04/14/2009 | US7517888 A1 adenosine receptor antagonists |
| 04/14/2009 | US7517887 Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof |
| 04/14/2009 | US7517858 Prodrugs of pharmaceuticals with improved bioavailability |
| 04/09/2009 | WO2009045175A1 Pyrimidine substituted purine derivatives |
| 04/09/2009 | WO2009045174A1 2-morpholinylpurines as inhibitors of pi3k |
| 04/09/2009 | WO2009043899A1 Drug transfer into living cells |
| 04/09/2009 | WO2009043320A2 Substituted 6-(alkylbenzylamino)purine derivatives for use as cytokinin receptor antagonists and preparations containing these derivatives |
| 04/09/2009 | US20090093633 Organic Compounds |
| 04/09/2009 | US20090093457 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 04/09/2009 | CA2701581A1 Pyrimidine substituted purine derivatives |
| 04/08/2009 | EP2044940A2 Methods of treating patients suffering from movement disorders |
| 04/08/2009 | EP2044070A1 Purine derivatives as a2a agonists |
| 04/08/2009 | EP2044054A2 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity |
| 04/08/2009 | EP2043655A2 Purine and deazapurine derivatives as pharmaceutical compounds |
| 04/08/2009 | EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 04/08/2009 | CN100475815C HIV-reproduction-inhibitive purinderivater |
| 04/07/2009 | US7514444 compounds that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are told |
| 04/07/2009 | CA2463294C Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/07/2009 | CA2458684C Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 04/07/2009 | CA2416706C Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |